Mirae Asset Global Investments’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-215,722
Closed -$6.13M 1659
2025
Q4
$6.13M Hold
215,722
0.02% 502
2025
Q3
$5.24M Buy
215,722
+14,717
+7% +$339K 0.02% 508
2025
Q2
$4.25M Sell
201,005
-22,099
-10% -$453K 0.01% 510
2025
Q1
$4.82M Buy
223,104
+45
+0% +$1K 0.02% 460
2024
Q4
$4.85M Sell
223,059
-36,674
-14% -$846K 0.02% 450
2024
Q3
$6.16M Buy
259,733
+48,137
+23% +$1.15M 0.03% 376
2024
Q2
$4.83M Hold
211,596
0.02% 392
2024
Q1
$4.69M Hold
211,596
0.01% 909
2023
Q4
$4.63M Hold
211,596
0.01% 917
2023
Q3
$4.19M Buy
211,596
+5,000
+2% +$102K 0.01% 911
2023
Q2
$4.22M Sell
206,596
-500
-0.2% -$10.5K 0.01% 939
2023
Q1
$4.28M Hold
207,096
0.01% 915
2022
Q4
$4.37M Sell
207,096
-91,500
-31% -$1.89M 0.01% 870
2022
Q3
$5.65M Sell
298,596
-29,600
-9% -$587K 0.02% 758
2022
Q2
$6.18M Buy
328,196
+14,600
+5% +$278K 0.02% 775
2022
Q1
$6.56M Hold
313,596
0.01% 790
2021
Q4
$7.44M Hold
313,596
0.02% 770
2021
Q3
$8.03M Buy
313,596
+187,596
+149% +$4.94M 0.02% 717
2021
Q2
$3.26M Buy
+126,000
New +$3.21M 0.01% 928

Other funds holding IBBQ

Mirae Asset Global Investments's IBBQ Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026, closing a stake of 215,722 shares — an estimated $6.13M sold.

Mirae Asset Global Investments first reported a position in IBBQ in Q2 2021 and held it in 19 quarters. The position peaked at $8.03M in Q3 2021. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 215,722 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $6.13M.
  • Mirae Asset Global Investments first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and held it in 19 quarters.
  • Mirae Asset Global Investments's Invesco NASDAQ Biotechnology ETF position peaked at $8.03M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.